Collectively, these results indicated that ERβ isoforms differentially modulate the mTOR, NFkB and JAK–STAT pathways in GBM cells, and suggested that ERβ1, but not ERβ5, displayed tumor-suppressing functions in GBMs. The gene discussed is ESR2; the disease is neoplasm.